Alt
Long

Time to get long GILD

NASDAQ:GILD   GILEAD SCIENCES INC
52 views
0
52 0
Gilled is an extremely strong company fundamentally with huge earnings growth. Stock was hid with uncertainty with competition or ABBY but their new Hep C drugs should still control 80-90% of market share. Also the retracement off the recent high has found solid support at the $100 level. The stock looks ready for a move higher
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out